Phase I Trial With Weekly Docetaxel, Capecitabine and Carboplatin as Induction Chemotherapy Followed by Concomitant Capecitabine and Radiotherapy in Patients With Locally Advanced Esophageal Cancer
Phase of Trial: Phase I
Latest Information Update: 20 Sep 2010
At a glance
- Drugs Docetaxel (Primary) ; Capecitabine; Carboplatin
- Indications Oesophageal cancer
- Focus Adverse reactions
- 20 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 30 Nov 2005 New trial record.